N-Boc-3-甲基-4-羟基哌啶结构式
|
常用名 | N-Boc-3-甲基-4-羟基哌啶 | 英文名 | 1-BOC4-HYDROXY-3-METHYLPIPERIDINE |
|---|---|---|---|---|
| CAS号 | 181269-70-5 | 分子量 | 215.289 | |
| 密度 | 1.1±0.1 g/cm3 | 沸点 | 301.4±35.0 °C at 760 mmHg | |
| 分子式 | C11H21NO3 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | 136.1±25.9 °C |
| 中文名 | N-Boc-3-甲基-4-羟基哌啶 |
|---|---|
| 英文名 | tert-butyl 4-hydroxy-3-methylpiperidine-1-carboxylate |
| 英文别名 | 更多 |
| 密度 | 1.1±0.1 g/cm3 |
|---|---|
| 沸点 | 301.4±35.0 °C at 760 mmHg |
| 分子式 | C11H21NO3 |
| 分子量 | 215.289 |
| 闪点 | 136.1±25.9 °C |
| 精确质量 | 215.152145 |
| PSA | 49.77000 |
| LogP | 1.10 |
| 蒸汽压 | 0.0±1.4 mmHg at 25°C |
| 折射率 | 1.484 |
| 储存条件 | 室温,干燥密封 |
| 海关编码 | 2933399090 |
|---|
|
~99%
N-Boc-3-甲基-4-羟基哌啶 181269-70-5 |
| 文献:TAKEDA PHARMACEUTICAL COMPANY LIMITED; TAKEDA CAMBRIDGE LIMITED; CARROLL, Colm; GOLDBY, Anne; TEALL, Martin Patent: WO2013/179024 A1, 2013 ; Location in patent: Page/Page column 56-57 ; |
|
~%
N-Boc-3-甲基-4-羟基哌啶 181269-70-5 |
| 文献:THE SCRIPPS RESEARCH INSTITUTE Patent: WO2007/82079 A2, 2007 ; Location in patent: Page/Page column 34-35 ; WO 2007/082079 A2 |
|
~%
N-Boc-3-甲基-4-羟基哌啶 181269-70-5 |
| 文献:NOVIRA THERAPEUTICS, INC.; HARTMAN, George D.; FLORES, Osvaldo A. Patent: WO2013/96744 A1, 2013 ; |
|
~%
N-Boc-3-甲基-4-羟基哌啶 181269-70-5 |
| 文献:NOVIRA THERAPEUTICS, INC.; HARTMAN, George D.; FLORES, Osvaldo A. Patent: WO2013/96744 A1, 2013 ; |
| N-Boc-3-甲基-4-羟基哌啶上游产品 4 | |
|---|---|
| N-Boc-3-甲基-4-羟基哌啶下游产品 2 | |
| 海关编码 | 2933399090 |
|---|---|
| 中文概述 | 2933399090. 其他结构含非稠合吡啶环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
| 申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期 |
| Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
| 2-Methyl-2-propanyl 4-hydroxy-3-methyl-1-piperidinecarboxylate |
| N-Boc-3-methyl-4-hydroxypiperidine |
| 1-Piperidinecarboxylic acid, 4-hydroxy-3-methyl-, 1,1-dimethylethyl ester |
| 1-Boc4-hydroxy-3-methylpiperidine |